Executive Profile

Anthony H. Wild Ph.D. General Partner, BOWS Pharmaceuticals AG

Age	Total Calculated Compensation	This person is connected to 6 Board Members in 6 different organizations across 12 different industries. See Board Relationships
63	--

Background

Dr. Anthony H. Wild, Tony, is a General Partner at BOWS Pharmaceuticals AG. Dr. Wild also co-founded BOWS Pharmaceuticals AG. Dr. Wild is also a Senior Advisor at Golden Pond Healthcare Inc. Prior to this, he was the Founding Partner, President, and Chief Executive Officer at MedPointe Capital Partners, LLC. Dr. Wild served as the Chairman and the Chief Executive Officer at MedPointe Inc. He was Co-Founder of Meda Pharmaceuticals, Inc. and served as its Chief Executive ... Officer from 2001 to May 1, 2006 and served as its Non-Executive Chairman. He served as Chief Executive Officer and Chairman of the Board of MedPointe Healthcare, Inc. Prior to that, Dr. Wild served as an Executive Vice President at Warner-Lambert and as the President of its Pharmaceutical Sector until June 2000. He was also the Chairman and first Chief Executive Officer at MedPointe Pharmaceuticals Inc. Dr. Wild had worldwide responsibility for Warner-Lambert's pharmaceutical commercial operations and research and development. Prior to joining Warner-Lambert in 1995, initially as the President of Parke-Davis North America before assuming global responsibilities in 1996, he spent 22 years , employed at Schering-Plough Corporation in Japan, the Netherlands, South Africa, Sweden, Switzerland, and the United States. He later became the President at Schering-Plough, for Japanese operations, including a complex web of licensee and licensor partnerships with major Japanese companies. Prior to this, Dr. Wild was a Development Chemist at Sandoz AG in Basel, Switzerland, where he worked on optimization and simulation of chemical processes. Dr. Wild serves as the Chairman of the Advisory Board of Ferrer Freeman & Company, LLC. He serves as the Non- Executive Chairman of MedPointe, Inc. He serves as the Chairman of Innocoll Inc. He serves as Member of International Commercial Advisory Board of Prismic Pharmaceuticals, Inc. He serves as a Director at Ranbaxy Laboratories Ltd. Dr. Wild is a Member of Advisory Board of Auven Therapeutics Management L.L.L.P. He serves as a Member of the Board of Directors Millennium Pharmaceuticals Inc. (Cambridge), Slate Pharmaceuticals, Inc., and Fovea S.A. (Paris). He served as a Director of Millennium Pharmaceuticals, Inc. since February 2006. He served as a Non-executive Director of Bioglan Pharma plc since February 1998. He served as a Director of Allergan Inc. Dr. Wild is a Member of the Board of Advisors of the Joseph L. Mailman School of Public Health at Columbia University and a Trustee of the Healthcare Institute of New Jersey. In the past, he was the Chairman of the International Section of Pharmaceutical Research and Manufacturers of America, and the Governor of the American Chamber of Commerce in Japan. Dr. Wild received Ph.D. in Physical Chemistry from Churchill College, University of Cambridge and graduated from the University of York with a B.A. honors degree in Chemistry.

Corporate Headquarters Bahnhofstrasse 7 Zug, -- 6301 Switzerland Phone: -- Fax: -- Board Members Memberships Former Director Allergan Inc. Non-Executive Independent Director, Member of Science Committee, Member of Audit Committee and Member of Compensation Committee Ranbaxy Laboratories Ltd. Co-Founder Meda Pharmaceuticals, Inc. Chairman Innocoll, Inc. Former Chairman and Chief Executive Officer MedPointe Healthcare, Inc. Director Slate Pharmaceuticals, Inc. 1998-N/A Former Non-executive Director Bioglan Pharma plc 2006-N/A Former Director, Member of Research & Development Committee and Member of Audit Committee Millennium Pharmaceuticals, Inc. Education Unknown/Other Education University of York Bachelor's Degree 1968 University of York BA University of York PhD University of Cambridge PhD Churchill College, University of Cambridge Other Affiliations Ferrer Freeman & Company, LLC Millennium Pharmaceuticals, Inc. Variagenics, Inc. Schering-Plough Corporation Allergan Inc. Carter-Wallace, Inc. Warner-Lambert Company LLC Ranbaxy Laboratories Ltd. Bioglan Pharma plc Meda Pharmaceuticals, Inc. MedPointe Capital Partners University of Cambridge University of York Innocoll, Inc. Churchill College, University of Cambridge MedPointe Healthcare, Inc. Golden Pond Healthcare, Inc. Auven Therapeutics Management L.L.L.P Slate Pharmaceuticals, Inc. Prismic Pharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.